North America
On 13 November, 16 new medicines joined Japan's National Health Insurance (NHI) price list. It was the last of the seven listing rounds Japan now runs each...
November 17, 2026 | Analysis
Development candidate demonstrates encouraging preclinical activity in CDKN2A-deficienct tumor models as a monotherapy and in combi...
November 17, 2026 | News
AstraZeneca, BASF, and Sanofi among 25+ enterprise customers, with more than 50 custom enzymes delivered Proceeds will grow the commercial team and US p...
November 13, 2026 | News
Blackstone to provide Pfizer up to $1.5 billion through 2028 to support clinical program for GLP-1 receptor agonist Pfizer Inc. (NYSE: PFE) and Blackstone...
November 13, 2026 | News
PIMJETMI® (pimicotinib) is a new systemic treatment option for certain U.S. adult patients with symptomatic tenosynovial giant cell tumor (TGCT), dem...
November 12, 2026 | News
First lentiviral-vector-based in vivo CAR-T product from China to receive a U.S. FDA IND clearance; a Phase Ib study in R/R B-NHL will be initiated directl...
November 12, 2026 | News
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System designed to identify patients with solid tumors with h...
November 12, 2026 | News
SINTBILO® (tafolecimab injection) monotherapy achieved significant reduction of LDL-C level, with > 60% mean LDL-C reduction after 12 weeks ...
November 10, 2026 | News
Data presented at AASLD The Liver Meeting demonstrated 100% of participants (28/28) who completed Week 96 of combination therapy reached undetectable v...
November 10, 2026 | News
33% investigator-assessed objective response rate and 90% disease control rate at 10 mg/kg every three weeks in patients with PD-(L)1-resistant/refrac...
November 09, 2026 | News
Cancer drugs keep improving, but their limits remain. When antibody therapies first emerged, only a fraction of patients benefited, and small-molecule anti...
November 09, 2026 | News
From millions of molecular measurements to clinically supported therapeutic predictions, Differentia is building AI-powered disease environments for pharma...
November 05, 2026 | News
Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites wit...
November 04, 2026 | News
Alkermes plc announced the initiation of a phase 2 study evaluating the safety and efficacy of ALKS 7290 as an adjunctive therapy to antidepressants ...
November 02, 2026 | News
Most Read
Bio Jobs
News